Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

Frontiers Personalized medicine in a community health system: the NorthShore experience

The road from next-generation sequencing to personalized medicine

Frontiers Microbiome in Death and Beyond: Current Vistas and Future Trends

Frontiers Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow

AI in Genomics and Reporting for Clinical Practice

Clinical application of next-generation sequencing to the practice of neurology - The Lancet Neurology

Genomics and epigenetics link to DNA structure Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Genomic medicine: cracking genomes to cure 'incurable' diseases

Forward-Looking Advances for Human Genetics and Genomics - ASHG

Bringing Cost and Process Efficiency to Next Generation Sequencing - Drug Discovery World (DDW)

Cool Companies - Connect San Diego